Compare MRTN & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRTN | KOD |
|---|---|---|
| Founded | 1946 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 850.3M | 795.5M |
| IPO Year | 1986 | 2018 |
| Metric | MRTN | KOD |
|---|---|---|
| Price | $11.67 | $22.69 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 6 |
| Target Price | $19.00 | ★ $22.67 |
| AVG Volume (30 Days) | ★ 761.1K | 720.6K |
| Earning Date | 01-26-2026 | 11-13-2025 |
| Dividend Yield | ★ 2.03% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.24 | N/A |
| Revenue | ★ $903,976,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.24 | N/A |
| P/E Ratio | $49.75 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.35 | $1.92 |
| 52 Week High | $17.43 | $26.21 |
| Indicator | MRTN | KOD |
|---|---|---|
| Relative Strength Index (RSI) | 71.43 | 53.57 |
| Support Level | $11.03 | $21.24 |
| Resistance Level | $11.93 | $26.21 |
| Average True Range (ATR) | 0.30 | 1.67 |
| MACD | 0.15 | -0.18 |
| Stochastic Oscillator | 87.47 | 35.39 |
Marten Transport Ltd is a temperature-sensitive truckload carrier in the United States. The company specializes in transporting and distributing food and other consumer packaged goods that require a temperature-controlled or insulated environment. It operates through four segments: Truckload, Dedicated, Intermodal, and Brokerage, generating the majority of its revenue from the Truckload segment. The Truckload segment offers a mix of regional short-haul and medium- to long-haul full-load transportation services.
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.